Our immune checkpoint poster, and exploring the one-biomarker-per-drug paradigm in oncology

Immune checkpoint poster   Download our immune checkpoint pathway poster and find out how the body's immune system can be used in the fight against cancer.   Get the poster

Exploring the one-biomarker-per-drug paradigm in oncology   We got the latest from a panel of experts on why one-biomarker-per-drug is insufficient and how this challenge could be solved.   Learn more

Immuno-oncology antibody panels   New immunohistochemistry-optimized panels of anti-human recombinant antibodies against key immuno-oncology targets.   See the panels

Diagnostic variation    We take a look at the source of the variability seen in PD1/PD-L1 antibody-based diagnostics, including protocol sensitivity.   Find out more

Cancer Immunotherapy Consortium    Register now for the Canadian Cancer Immunotherapy Consortium featuring keynote speaker Nobel prize-winning Tasuku Honjo.   Register now

PD-1/PD-L1 checkpoint pathway   Learn about the PD-1/PD-L1 checkpoint pathway, its function in cancer, and how it is being used in immunotherapy.   Learn more

Compare PD-L1 antibody clones   Get access to four of our key recombinant monoclonal PD-L1 antibody clones. Which one will work best for you?   See the clones